HTL-Strefa Inc. Presents DropSafe® Sicura™, A European-Made Passive Safety Needle, Amid FDA Concerns Over Chinese Medical Supplies

In a recent advancement in healthcare safety, HTL-Strefa Inc. introduces DropSafe® Sicura™, the first fully passive safety needle available in North America. This innovation aims to minimize needlestick injuries, offering a safer injection experience. The introduction of this FDA-cleared device comes as a direct response to the U.S. Food and Drug Administration's (FDA) warnings about the quality of plastic syringes and safety needles manufactured in China.

Engineered and produced in Europe, DropSafe® Sicura™ emphasizes the highest standards in patient care by reducing the risk of needlestick injuries with a transparent shield that locks automatically post-injection. This level of safety and reliability is crucial at a time when the healthcare industry faces challenges with the performance of certain medical supplies.

Highlighting HTL-Strefa Inc.'s commitment to providing secure and reliable healthcare solutions, General Manager Carl Ward reassures the healthcare community of the company's capacity to meet the growing demand for safer medical supplies in the U.S. and Canada. DropSafe® Sicura™ is a testament to HTL-Strefa Inc.'s legacy of excellence and innovation in medical technology for over three decades, ensuring minimal disruption to patient care during transitions to safer alternatives.